Preoperative Volume-Based PET Parameter, MTV2.5, as a Potential Surrogate Marker for Tumor Biology and Recurrence in Resected Pancreatic Cancer.

about

Metabolic tumor burden quantified on [18F]FDG PET/CT improves TNM staging of lung cancer patients.Heterogeneity index evaluated by slope of linear regression on 18F-FDG PET/CT as a prognostic marker for predicting tumor recurrence in pancreatic ductal adenocarcinoma.

P2860

Q47735250-4CD8028A-EC86-4B26-A339-431DA492296B Q47850078-6730FDFB-BB77-4441-AA94-6A7F43AACB42

P2860

Preoperative Volume-Based PET Parameter, MTV2.5, as a Potential Surrogate Marker for Tumor Biology and Recurrence in Resected Pancreatic Cancer.

Item

http://www.wikidata.org/entity/Q36663805

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Preoperative Volume-Based PET ...... in Resected Pancreatic Cancer.

@ast

Preoperative Volume-Based PET ...... in Resected Pancreatic Cancer.

@en

type

Item

label

Preoperative Volume-Based PET ...... in Resected Pancreatic Cancer.

@ast

Preoperative Volume-Based PET ...... in Resected Pancreatic Cancer.

@en

prefLabel

Preoperative Volume-Based PET ...... in Resected Pancreatic Cancer.

@ast

Preoperative Volume-Based PET ...... in Resected Pancreatic Cancer.

@en

P1476

Preoperative Volume-Based PET ...... in Resected Pancreatic Cancer.

@en

P2093

Sung Hwan Lee

http://www.w3.org/2001/XMLSchema#string

Woo Jung Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Pancreatic cancer

Progression model for pancreatic cancer.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy.

Perineural invasion by ductal adenocarcinoma of the pancreas.

Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy.

Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent.

Partial-volume effect in PET tumor imaging.

Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer.

Redefining the R1 resection for pancreatic ductal adenocarcinoma: tumour lymph nodal burden and lymph node ratio are the only prognostic factors associated with survival.

P304

e2595

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000002595

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ho Kyoung Hwang

Chang Moo Kang

Mijin Yun

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26945350

http://www.w3.org/2001/XMLSchema#string

P932

4782834

http://www.w3.org/2001/XMLSchema#string

Preoperative Volume-Based PET Parameter, MTV2.5, as a Potential Surrogate Marker for Tumor Biology and Recurrence in Resected Pancreatic Cancer.

about

P2860

P2860

Preoperative Volume-Based PET Parameter, MTV2.5, as a Potential Surrogate Marker for Tumor Biology and Recurrence in Resected Pancreatic Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932